GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Price-to-Operating-Cash-Flow

Hainan Poly Pharm Co (SZSE:300630) Price-to-Operating-Cash-Flow : 14.11 (As of May. 16, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Price-to-Operating-Cash-Flow?

As of today (2024-05-16), Hainan Poly Pharm Co's share price is ¥12.35. Hainan Poly Pharm Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was ¥0.88. Hence, Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow Ratio for today is 14.11.

The historical rank and industry rank for Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:300630' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 14.11   Med: 68.01   Max: 433.94
Current: 14.11

During the past 11 years, Hainan Poly Pharm Co's highest Price-to-Operating-Cash-Flow Ratio was 433.94. The lowest was 14.11. And the median was 68.01.

SZSE:300630's Price-to-Operating-Cash-Flow is ranked better than
59.38% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.48 vs SZSE:300630: 14.11

Hainan Poly Pharm Co's Cash Flow from Operations per share for the three months ended in Sep. 2023 was ¥-0.09. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was ¥0.88.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hainan Poly Pharm Co was 388.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 31.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 21.40% per year.

During the past 11 years, Hainan Poly Pharm Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.50% per year. The lowest was 6.70% per year. And the median was 14.95% per year.


Hainan Poly Pharm Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Price-to-Operating-Cash-Flow Chart

Hainan Poly Pharm Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.20 72.78 55.26 153.74 21.57

Hainan Poly Pharm Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 138.27 21.57 27.28 19.75 24.79

Competitive Comparison of Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow falls into.



Hainan Poly Pharm Co Price-to-Operating-Cash-Flow Calculation

Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=12.35/0.875
=14.11

Hainan Poly Pharm Co's Share Price of today is ¥12.35.
Hainan Poly Pharm Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.88.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Hainan Poly Pharm Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Poly Pharm Co (SZSE:300630) Business Description

Traded in Other Exchanges
N/A
Address
No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051
Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines